By Tony Winterburn • Published: 30 Jul 2020 • 13:24
THE US government has backed Johnson & Johnson with €400 million worth of funding in the hope of speeding production of the vaccine.
Johnson & Johnson has started human safety trials for its Covid-19 vaccine after releasing details of a study in monkeys that showed its best-performing vaccine candidate offered strong protection in a single dose.
According to the study, which was published in the journal Nature, when exposed to the virus, all the six animals in the trial who received the candidate vaccine were completely protected from lung disease and five out of six were protected from infection as measured by the presence of the virus in nasal swabs.
The US government is backing Johnson & Johnson (J&J) with €400 million in funding in hope of speeding production of a vaccine to end the pandemic.
Share this story
Subscribe to our Euro Weekly News alerts to get the latest stories into your inbox!
By signing up, you will create a Euro Weekly News account if you don't already have one. Review our Privacy Policy for more information about our privacy practices.
Share your story with us by emailing newsdesk@euroweeklynews.com, by calling +34 951 38 61 61 or by messaging our Facebook page www.facebook.com/EuroWeeklyNews
Right. I´ll believe that that is safe when millions of other people have had it without anyone dying or being seriously ill. Let´s see…….
Comments are closed.
By signing up, you will create a Euro Weekly News account if you don’t already have one. Review our Privacy Policy for more information about our privacy practices.
Download our media pack in either English or Spanish.